Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy

Both fluoroquinolones (FQs) and third-generation cephalosporins (3rd-GCs) are commonly prescribed to treat bloodstream infections, but comparative efficacies between them were rarely studied. Demographics and clinical characteristics of 733 adults with polymicrobial or monomicrobial community-onset...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Lee, Ching-Chi, Wang, Jiun-Ling, Lee, Chung-Hsun, Hsieh, Chih-Chia, Hung, Yuan-Pin, Hong, Ming-Yuan, Tang, Hung-Jen, Ko, Wen-Chien
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2017
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278695/
https://ncbi.nlm.nih.gov/pubmed/27855072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02174-16
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares